-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, S5VvZEbF6TFmQoU6sm73ls7w4k2Bx6RA3yYkVjKTr/esncv9Wmfx0nJ4GD5OTF2m VuC6akK51d55UTql1MaYvg== 0001209191-04-017890.txt : 20040329 0001209191-04-017890.hdr.sgml : 20040329 20040329204828 ACCESSION NUMBER: 0001209191-04-017890 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040329 FILED AS OF DATE: 20040329 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JEW JEANNE Y CENTRAL INDEX KEY: 0001235946 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-28298 FILM NUMBER: 04697901 BUSINESS ADDRESS: STREET 1: C/O ONYX PHARMECEUTICALS INC STREET 2: 3031 RESEARCH DR BLDG A CITY: RICHMOND STATE: CA ZIP: 94806 BUSINESS PHONE: 5102229700 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ONYX PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001012140 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943154463 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3031 RESEARCH DR STREET 2: BLDG A CITY: RICHMOND STATE: CA ZIP: 94806 BUSINESS PHONE: 5102229700 MAIL ADDRESS: STREET 1: 3031 RESEARCH DRIVE CITY: RICHMOND STATE: CA ZIP: 94806 4 1 doc4.xml FORM 4 SUBMISSION X0201 4 2004-03-29 0 0001012140 ONYX PHARMACEUTICALS INC ONXX 0001235946 JEW JEANNE Y C/O ONYX PHARMACEUTICALS, INC. 3031 RESEARCH DR., BLDG. A RICHMOND CA 94806 0 1 0 0 VP, Corporate & Commercial Dev Common Stock 2004-03-29 4 M 0 1200.0000 6.4600 A 1200.0000 D Common Stock 2004-03-29 4 M 0 1000.0000 5.0000 A 2200.0000 D Common Stock 2004-03-29 4 S 0 2200.0000 39.9600 D 0 D Stock Option (Right to Buy) 6.4600 2004-03-29 4 M 0 1200.0000 0 D 2003-11-25 2012-11-24 Common Stock 1200.0000 83800.0000 D Stock Option (Right to Buy) 5.0000 2004-03-29 4 M 0 1000.0000 0 D 2004-08-12 2013-02-11 Common Stock 1000.0000 14000.0000 D The shares subject to the option become exercisable as to 25% on the first anniversary of the date of grant and 1/48th monthly thereafter. The shares subject to the option become exercisable as to 12.5% on the date 6 months following the date of grant and 1/48th monthly thereafter. /s/ Marilyn E. Wortzman, Attorney-in-fact 2004-03-29 -----END PRIVACY-ENHANCED MESSAGE-----